Childrens Non Aspirin

Description

Children's Non-Aspirin is a pediatric formulation designed for the relief of pain and fever. This product is specifically formulated without aspirin, making it suitable for use in children to avoid the risk of Reye's syndrome associated with aspirin use in this population. The formulation is intended to provide effective symptom management while ensuring safety for young patients.

Uses and Indications

This drug is indicated for the reduction of fever and the relief of minor aches and pains associated with various conditions, including the common cold, influenza, headache, sore throat, and toothache.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

Healthcare professionals should ensure that the medication is administered according to the following guidelines. Prior to use, the product must be shaken well. The appropriate dose should be determined using the dosage chart provided below, with weight being the preferred method for dosing; if weight is not available, age may be used as an alternative.

Dosing should not exceed the recommended limits. The maximum frequency of administration is every 4 hours, with a maximum of 5 doses within a 24-hour period.

Dosage Chart:

• For patients weighing under 24 lb or under 2 years of age, consult a physician for the appropriate dose.

• For patients weighing 24-35 lb or aged 2-3 years, the recommended dose is 1 teaspoon (5 mL).

• For patients weighing 36-47 lb or aged 4-5 years, the recommended dose is 1 1/2 teaspoons (7.5 mL).

• For patients weighing 48-59 lb or aged 6-8 years, the recommended dose is 2 teaspoons (10 mL).

• For patients weighing 60-71 lb or aged 9-10 years, the recommended dose is 2 1/2 teaspoons (12.5 mL).

• For patients weighing 72-95 lb or aged 11 years, the recommended dose is 3 teaspoons (15 mL).

It is imperative to use only the enclosed dosing cup specifically designed for this product. The use of any other dosing device is not recommended.

Contraindications

Use of this product is contraindicated in patients who are concurrently using any other product that contains acetaminophen. This is due to the potential risk of acetaminophen overdose, which can lead to serious liver damage.

Warnings and Precautions

Severe sore throat may indicate a more serious condition. If a patient experiences a sore throat that is severe, persists for more than two days, or is accompanied by fever, headache, rash, nausea, or vomiting, it is imperative to consult a healthcare professional promptly.

This product should not be used in conjunction with any other medication containing acetaminophen, as this may increase the risk of adverse effects.

Patients are advised to discontinue use and seek medical advice if any new symptoms arise, if there is evidence of redness or swelling, if pain worsens or persists beyond five days, or if fever intensifies or lasts longer than three days.

An overdose of this medication can lead to significant liver damage. It is crucial to adhere strictly to the recommended dosage. In the event of an overdose, immediate medical assistance should be sought, or the Poison Control Center (1-800-222-1222) should be contacted without delay. Rapid medical intervention is essential, even if the patient does not exhibit any immediate signs or symptoms of overdose.

Side Effects

Patients may experience a range of adverse reactions associated with the use of this medication. Serious adverse reactions include the potential for liver damage in cases of overdose. It is critical for patients to seek immediate medical attention or contact a Poison Control Center (1-800-222-1222) if they suspect an overdose, even in the absence of noticeable signs or symptoms.

Common adverse reactions warranting caution include severe sore throat, particularly if it persists for more than two days or is accompanied by fever, headache, rash, nausea, or vomiting. In such instances, patients are advised to consult a healthcare professional promptly. Additionally, patients should discontinue use and seek medical advice if new symptoms arise, if redness or swelling occurs, if pain worsens or lasts longer than five days, or if fever intensifies or persists beyond three days.

It is important to note that this medication should not be used in conjunction with any other product containing acetaminophen, as this may increase the risk of adverse effects.

Drug Interactions

Co-administration of this medication with any other product containing acetaminophen is contraindicated. The combination may lead to an increased risk of acetaminophen-related hepatotoxicity. It is advised that healthcare professionals ensure patients are not using multiple acetaminophen-containing products concurrently to mitigate the risk of liver damage. Monitoring of liver function may be warranted in patients who have inadvertently taken such combinations.

Packaging & NDC

Below are the non-prescription pack sizes of Childrens Non Aspirin (acetaminophen). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should not exceed the recommended dosage as outlined in the prescribing information. Dosing should ideally be based on weight; however, age can be used if weight is not available. The following dosing chart provides guidance:

• For patients under 24 lb (under 2 years), consultation with a healthcare professional is advised.

• For patients weighing 24-35 lb (ages 2-3), the recommended dose is 1 tsp (5 mL).

• For patients weighing 36-47 lb (ages 4-5), the recommended dose is 1 1/2 tsp (7.5 mL).

• For patients weighing 48-59 lb (ages 6-8), the recommended dose is 2 tsp (10 mL).

• For patients weighing 60-71 lb (ages 9-10), the recommended dose is 2 1/2 tsp (12.5 mL).

• For patients weighing 72-95 lb (age 11), the recommended dose is 3 tsp (15 mL).

Doses may be repeated every 4 hours as needed, but should not exceed 5 doses in a 24-hour period. It is crucial to use only the enclosed dosing cup specifically designed for this product; other dosing devices should not be used. Additionally, this product should be kept out of reach of children to prevent accidental overdose.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any adverse effects or changes in therapeutic response, given the lack of targeted data for this population.

Pregnancy

There are no specific statements regarding the use of Children's Non-Aspirin - acetaminophen liquid during pregnancy, including safety concerns, dosage modifications, or special precautions. Healthcare professionals should consider the absence of data when advising pregnant patients. As with any medication, the potential benefits must be weighed against any unknown risks to fetal outcomes. Women of childbearing potential should be counseled accordingly, and alternative treatments should be considered if necessary.

Lactation

There are no specific warnings or recommendations regarding the use of this product by lactating mothers. Additionally, there are no statements concerning the potential for excretion in breast milk or any associated risks to breastfed infants during the use of this product.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment may be at an increased risk of liver damage, particularly in the event of an overdose. It is essential for healthcare providers to monitor liver function closely in these patients. In cases of overdose, immediate medical assistance should be sought, and contacting a Poison Control Center (1-800-222-1222) is advised. Prompt medical attention is critical, even if the patient does not exhibit any signs or symptoms of liver damage. Adjustments to dosing or additional monitoring may be necessary based on the severity of the hepatic impairment, although specific dosage changes are not detailed in the provided information.

Overdosage

In the event of an overdose, defined as the ingestion of more than the recommended dose, there is a significant risk of liver damage. Healthcare professionals should be aware that symptoms may not be immediately apparent, making it essential to act swiftly.

Immediate medical assistance is crucial. In cases of suspected overdose, it is imperative to seek medical help or contact a Poison Control Center at 1-800-222-1222 without delay. Quick intervention is vital, even if the patient does not exhibit any noticeable signs or symptoms of overdose. Prompt evaluation and management can mitigate potential complications associated with liver damage.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

No postmarketing experience details are available in the provided data.

Patient Counseling

Healthcare providers should advise patients to keep the medication out of reach of children to prevent accidental ingestion. It is important to inform patients not to use this product in conjunction with any other medications that contain acetaminophen, as this may lead to an increased risk of adverse effects.

Patients should be instructed to discontinue use and consult a healthcare professional if they experience new symptoms, or if they notice any redness or swelling at the site of application. Additionally, they should be made aware that if their pain worsens or persists for more than five days, or if their fever intensifies or lasts longer than three days, they should seek medical advice promptly. This guidance is essential to ensure patient safety and effective management of their condition.

Storage and Handling

The product is supplied in a configuration that includes a protective bottle wrap and a foil inner seal imprinted with "SEALED for YOUR PROTECTION." It is essential to ensure that these seals are intact before use, as the product should not be utilized if the bottle wrap or foil inner seal is broken or missing.

Storage conditions require the product to be maintained at a temperature range of 20-25°C (68-77°F). For proper identification, the lot number and expiration date can be found on the bottom panel of the container.

Additional Clinical Information

The medication is administered orally. Clinicians should advise patients to keep the medication out of reach of children. In the event of an overdose, it is crucial for patients to seek medical assistance or contact a Poison Control Center (1-800-222-1222) immediately, as prompt medical attention is essential even if no signs or symptoms are present.

Drug Information (PDF)

This file contains official product information for Childrens Non Aspirin, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)